Robert Lanza discusses two-year follow-up findings of human embryonic stem-cell transplantation in the potential treatment of Stargardt's Macular dystrophy and age-related macular degeneration.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv